$MOJO
EQUATOR Beverage Company

2023 Q1 Form 10-Q Financial Statement

#000149315223013325 Filed on April 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $515.6K $351.8K $379.7K
YoY Change 35.81% -17.0%
Cost Of Revenue $313.5K $224.3K $232.6K
YoY Change 34.77% -18.9%
Gross Profit $202.2K $127.4K $147.1K
YoY Change 37.46% -13.44%
Gross Profit Margin 39.21% 36.23% 38.74%
Selling, General & Admin $194.9K $191.2K $281.6K
YoY Change -30.78% -4.05%
% of Gross Profit 96.41% 150.07% 191.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $194.9K $191.2K $281.6K
YoY Change -30.78% -4.05%
Operating Profit $7.264K -$63.81K -$134.5K
YoY Change -105.4% 22.48%
Interest Expense $2.780K
YoY Change
% of Operating Profit 38.27%
Other Income/Expense, Net -$2.780K -$3.480K -$890.00
YoY Change 212.36%
Pretax Income $4.485K -$67.28K -$135.4K
YoY Change -103.31% 29.14%
Income Tax $13.34K $0.00
% Of Pretax Income 297.44%
Net Earnings $4.485K -$67.28K -$135.4K
YoY Change -103.31% 29.14% -1170.78%
Net Earnings / Revenue 0.87% -19.13% -35.66%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$8.727K
COMMON SHARES
Basic Shares Outstanding 16.47M shares 15.51M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.65K $10.74K $24.69K
YoY Change 64.64% -76.89%
Cash & Equivalents $40.65K $10.74K $24.69K
Short-Term Investments
Other Short-Term Assets $47.41K $68.25K $50.43K
YoY Change -5.99% 71.44%
Inventory $229.4K $268.3K $364.1K
Prepaid Expenses $16.88K $23.36K
Receivables $160.1K $93.85K $113.5K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $477.6K $441.1K $552.7K
YoY Change -13.59% 2.71%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.00 $1.00 $0.00
YoY Change -66.67%
TOTAL ASSETS
Total Short-Term Assets $477.6K $441.1K $552.7K
Total Long-Term Assets $1.00 $1.00 $0.00
Total Assets $477.6K $441.1K $552.7K
YoY Change -13.59% 2.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $78.25K $70.25K $179.4K
YoY Change -56.37% 19.19%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $235.0K $225.0K $127.4K
YoY Change 84.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $313.2K $295.3K $306.8K
YoY Change 2.11% 400.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $313.2K $295.3K $306.8K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $313.3K $295.3K $306.8K
YoY Change 2.12% 400.93%
SHAREHOLDERS EQUITY
Retained Earnings -$23.62M -$23.63M
YoY Change 1.02%
Common Stock $23.79M $16.23K
YoY Change -99.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $164.3K $145.9K $245.9K
YoY Change
Total Liabilities & Shareholders Equity $477.6K $441.1K $552.7K
YoY Change -13.59% 2.71%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income $4.485K -$67.28K -$135.4K
YoY Change -103.31% 29.14% -1170.78%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $19.91K $51.12K -$47.55K
YoY Change -141.87% 811.23%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $10.00K -50.00K 25.75K
YoY Change -61.17% 920.41%
NET CHANGE
Cash From Operating Activities $19.91K 51.12K -47.55K
Cash From Investing Activities
Cash From Financing Activities $10.00K -50.00K 25.75K
Net Change In Cash $29.91K 1.120K -21.80K
YoY Change -237.19% 57.75%
FREE CASH FLOW
Cash From Operating Activities $19.91K $51.12K -$47.55K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07302
CY2023Q1 dei City Area Code
CityAreaCode
929
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
264 7944
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16469115 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40646 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10738 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
160120 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
93852 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
229410 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
268289 usd
CY2023Q1 us-gaap Retainage Deposit
RetainageDeposit
30420 usd
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Jersey City
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001414953
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-55269
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
EQUATOR Beverage Company
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0884348
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
185 Hudson Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Floor 25
CY2022Q4 us-gaap Retainage Deposit
RetainageDeposit
44772 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
16880 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
23355 usd
CY2023Q1 us-gaap Security Deposit
SecurityDeposit
113 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
113 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
477589 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
441119 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
78245 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
70252 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
313245 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
295252 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16469115 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16469115 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16230615 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16230615 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
16470 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
16231 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
23772670 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
23758917 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23624796 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23629281 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
164344 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
145867 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
477589 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
441119 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
515633 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
379657 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
313457 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
232584 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
202176 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
147073 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
194912 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
281566 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7264 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-134493 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2780 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-886 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4485 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-135379 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4485 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-135379 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16461165 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15512895 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4485 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-135379 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
13992 usd
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
112005 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
66268 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4871 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-38879 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
129499 usd
CY2023Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-14352 usd
CY2022Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
12000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-6475 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1382 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7993 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
120817 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19908 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47545 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
70000 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
192000 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
60000 usd
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
65000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
101250 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25750 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29908 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21795 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10738 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46481 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40646 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24686 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
145867 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13992 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4485 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
164344 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
370553 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
112005 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
101250 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-135379 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-135379 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
245929 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zjeDKujYo2U1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zGW71pUOdYml">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements are prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1135639 usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1131038 usd
CY2022Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1135639 usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1131038 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7570924 usd
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7540252 usd
CY2022Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-2 reverse split
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
effect a 1-for-2 reverse split of the Company’s Common Stock.
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd

Files In Submission

Name View Source Status
0001493152-23-013325-index-headers.html Edgar Link pending
0001493152-23-013325-index.html Edgar Link pending
0001493152-23-013325.txt Edgar Link pending
0001493152-23-013325-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
mojo-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mojo-20230331_cal.xml Edgar Link unprocessable
mojo-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
mojo-20230331_def.xml Edgar Link unprocessable
mojo-20230331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed